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Abstract
Aims/hypothesis The purpose of the study was to evaluate
the association between retinal vascular calibre and micro-
and macrovascular complications in a population-based
cohort of Danish type 1 diabetic patients.
Methods This was a cross-sectional study of 208 long-
surviving type 1 diabetic patients from a population-based
Danish cohort. Retinal photographs were obtained at a
clinical examination attended by each participant in 2007–
2008, and retinal vascular calibre was measured and
summarised as the central retinal artery or vein equivalent
(CRAE or CRVE) using a computer-based program and a
standardised protocol. Associations between retinal vascu-
lar calibre and micro- and macrovascular complications
were examined after adjusting for confounding clinical
characteristics.
Results Retinal photographs were gradable for 188 of 208
patients (90.3%). The median age and duration of diabetes
for patients with gradable photos were 57.9 and 42 years,
respectively. After multivariate adjustments, individuals
with narrower retinal arterioles were more likely to have
nephropathy (OR 2.17, 95% CI 1.29–3.68, per SD decrease
in CRAE) and macrovascular disease (OR 3.17, 95% CI
1.59–6.34, per SD decrease in CRAE), but not neuropathy
(OR 1.10, 95% CI 0.70–1.71, per SD decrease in CRAE).
Retinal venular calibre was not associated with any micro-
or macrovascular complications.
Conclusions/interpretation In type 1 diabetic patients, retinal
arteriolar narrowing is associated with nephropathy and
macrovascular disease independently of other clinical charac-
teristics. If supported by further prospective studies, measure-
ment of retinal vessel diameter may allow a non-invasive
evaluation of the risk of diabetes-related complications.
Keywords Macrovascular disease . Nephropathy .
Neuropathy . Retinal vessel calibre . Type 1 diabetes
Abbreviations
AVR Arteriolar venular ratio
CRAE Central retinal artery equivalent
CRVE Central retinal vein equivalent
WESDR Wisconsin Epidemiologic Study of Diabetic
Retinopathy
Introduction
Examination of the human retinal vasculature allows direct
in vivo observation of the microvascular system. Quantita-
tive assessments of retinal vascular calibre have shown
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associations with the risk of micro- [1, 2] and macro-
vascular [1, 3–5] disease in studies of type 1 diabetic
patients. Further research is important to determine the
value of retinal imaging as a non-invasive test to predict
micro- and macrovascular complications in patients with
diabetes. However, most studies on retinal calibre have
been carried out in the general population and in individ-
uals with type 2 diabetes. The aim of this study was to
examine the relationship between retinal vascular calibre
and long-term micro- and macrovascular complications in a
population-based cohort of Danish type 1 diabetic patients.
Methods
Study population Study participants were identified based
on insulin prescriptions in a population-based cohort of all
type 1 diabetic patients from Fyn County, Denmark, with
an onset of diabetes before the age of 30 (n=727) identified
as of 1 July 1973. In 2007, 208 of 320 surviving patients
(65.0%) agreed to participate in an examination.
Examination The examinations took place between 1
March 2007 and 1 March 2008 and were performed by a
single examiner (J. Grauslund). The study was approved by
the local ethics committee, and all participants gave a
written informed consent. A full medical history was
obtained. An Omron M4 (Omron, Matsusaka, Japan) was
used for blood pressure measurement. A history of smoking
was obtained. One pack-year was defined as 20 cigarettes
smoked in 1 year.
Measurement of HbA1c was performed by cation
exchange chromatography using Tosoh G8 HPLC equip-
ment (Medinor, Broendby, Denmark) with reagents as
recommended by the supplier. Nephropathy was evaluated
in a single spot urine sample. Definitions were: normoal-
buminuria, 0–19 mg/l: microalbuminuria, 20–200 mg/l; and
macroalbuminuria, 201 mg/l and above. A monofilament
test (Bailey Instruments, Manchester, UK) was used to test
for neuropathy. Data on macrovascular disease were
obtained from the Danish National Patient Registry. Macro-
vascular disease was defined as a history of at least one of
the following events: stroke, myocardial infarction, angina
pectoris, percutaneous coronary intervention, coronary
bypass surgery or limb amputation.
Retinal photography and assessment Pupils were dilated
and fundus photographs were taken in both eyes. Nine 45°
colour fields were captured with a Topcon TRC-NW6S
(Topcon, Tokyo, Japan) and were automatically combined
as a mosaic image with IMAGEnet. Photographs were
graded for proliferative diabetic retinopathy at the Ocular
Epidemiology Research Services, Madison, WI, USA. For
each patient, the final category was determined by the
worse eye.
Retinal vascular calibre was measured using a computer-
based program following previously validated protocols
[6]. One disc-centred image was used for this measurement.
For each photograph, the largest six arterioles and venules
coursing through an area one-half to one disc diameter from
the optic disc were measured and summarised as the central
retinal artery equivalent (CRAE) and the central retinal vein
equivalent (CRVE) using formulae proposed by Knudtson
et al. [6]. The arteriolar venular ratio (AVR) was defined as
the ratio of CRAE to CRVE. The AVR has been suggested
as a useful indicator for changes in retinal arteriolar calibre.
Use of the AVR as a common measure of retinal vascular
calibres also minimises the effect of magnification differ-
ences associated with refractive error [7].
A high inter-eye correlation has been showed between
right and left eyes, and consequently we only used the right
eye for grading [8]. Left eye measurements were used when
photographs of the right eye were not of sufficient quality
for grading. All measurements were performed by a single
trained grader (J. Grauslund). Intergrader reproducibility,
determined by re-grading randomly chosen photographs
from 20 individuals, was high (intra-class correlation
coefficients of 0.96 and 0.99 for CRAE and CRVE,
respectively).
Statistical analyses Categorical data are presented as
percentages and continuous data are presented as medians
and interquartile ranges (25th to 75th percentiles). All
statistical differences were tested at the 0.05 level. The χ2
test was used for categorical data. For continuous data we
used the Mann–Whitney test for two groups and Cuzick’s
test for trend for several groups. Multiple logistic regression
models were used to obtain the ORs for nephropathy,
neuropathy and macrovascular disease in relation to retinal
calibre. Two models were used: an age- and sex-adjusted
model and a multivariate model. The latter was adjusted for
age, sex, duration of diabetes, HbA1c, systolic blood
pressure and pack-years of smoking. Furthermore, CRAE
and CRVE were entered simultaneously to control for errors
due to magnification. Stata Intercooled 9.2 was used for all
analyses.
Results
Two hundred and eight patients were examined. Twenty
patients had to be excluded as retinal vessel calibre could
not be measured in any eye. The median age and duration
of diabetes for patients included were 57.9 and 42 years,
respectively.
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In univariate analyses, narrow retinal arteriolar calibre
was related to poor glycaemic control and systolic blood
pressure (Table 1). Venular narrowing was also related to
systolic blood pressure and, furthermore, a larger CRVE
was found among smokers. Finally, a low AVR was
associated with a short duration of diabetes and smoking.
In additional univariate analyses, arteriolar narrowing was
related to nephropathy and proliferative diabetic retinopathy.
Median CRAEs were 143.3 µm, 134.0 µm and 127.1 µm for
patients with normo-, micro- and macroalbuminuria, respec-
tively (p<0.01), and vessel calibre was significantly narrower
in patients who had panretinal photocoagulation for prolif-
erative retinopathy (CRAE: 131.1 vs 147.5 µm, p<0.01;
CRVE: 198.5 vs 214.9 µm, p<0.01; AVR 0.65 vs 0.68, p=
0.02) (data not shown).
A logistic regression was performed to evaluate the
correlation between retinal vessel calibre and nephropathy,
neuropathy and macrovascular diseases. Results are pre-
sented in Table 2 for the age- and sex-adjusted model and
the multivariate model. In multivariate analyses, associa-
tions were found for retinal arteriolar calibre. The odds
ratios for nephropathy and macrovascular disease were 2.17
(95% CI 1.29–3.68) and 3.17 (95% CI 1.59–6.34),
respectively, for each SD decrease in CRAE. The same
associations were found for AVR. However, there were no
associations between CRVE and any of the complications.
Discussion
In this study, we report on associations between retinal
vascular calibre, measured from fundus photographs using
a computer-based program, and diabetes-related micro- and
macrovascular complications in a population-based cohort
of Danish type 1 diabetic patients. We found that retinal
arteriolar narrowing (and a low AVR) was associated with
Table 1 Relationship between retinal vessel calibre and clinical characteristics





Median (IQR) p value Median (IQR) p value Median (IQR) p value
Age (years) 0.32 0.10 0.07
37.7–52.7 62 141.5±24.9 208.9±36.1 0.65±0.09
53.0–61.8 62 142.9±24.4 211.1±29.8 0.67±0.08
61.9–84.4 64 139.0±17.6 208.0±37.9 0.69±0.10
Duration of diabetes (years) 0.42 0.06 0.04*
34–39 64 142.9±20.4 215.8±33.4 0.65±0.08
40–45 58 140.0±24.8 205.5±36.8 0.68±0.11
46–70 66 139.8±21.8 209.3±35.2 0.68±0.09
HbA1c (%) 0.01* 0.22 0.24
5.4–7.2 63 142.6±22.7 209.5±25.0 0.68±0.08
7.3–8.0 60 142.0±23.6 209.3±29.5 0.66±0.08
8.1–13.3 62 133.8±23.3 207.3±48.9 0.67±0.09
Systolic BP (mmHg) 0.02* 0.04* 0.83
102–139 64 145.1±25.0 211.9±41.3 0.68±0.11
140–155 61 140.5±19.2 209.5±23.6 0.67±0.07
156–235 63 136.0±22.0 207.3±39.4 0.66±0.09
Diastolic BP (mmHg) 0.60 0.17 0.13
52–71 62 141.2±24.3 212.9±32.1 0.66±0.09
72–79 64 140.7±24.8 206.8±42.0 0.69±0.07
80–109 62 140.6±20.3 207.6±26.2 0.67±0.09
Smoking (pack-years) 0.44 0.01* 0.03*
0 78 140.0±29.4 204.8±30.8 0.68±0.09
1–20 54 141.5±17.4 214.0±31.8 0.68±0.08
21–120 56 142.1±22.5 214.9±41.7 0.64±0.09
Data are presented as medians and interquartile ranges (25th to 75th percentiles), and p was tested for trend
*Statistically significant, p<0.05
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nephropathy and macrovascular disease, independently of
other clinical characteristics. No relationships were found
with retinal venular diameter.
The association of retinal arteriolar narrowing and protein-
uria confirms cross-sectional results from the Wisconsin
Epidemiologic Study of Diabetic Retinopathy (WESDR) [1].
Patients with type 1 diabetes with proteinuria had narrower
retinal arterioles—by about 20 µm—than those without
proteinuria. However, the same association was not found in
a 16 year follow-up of the WESDR [2]. Wong and co-
authors speculate that selective mortality in individuals with
retinal arteriolar narrowing and renal disease might be the
reason for the lack of associations [2].
In multivariate analyses, we found macrovascular disease
to be associated with narrower retinal arterioles. The same
association was also seen in the WESDR study for type 1
diabetic patients [1, 4]. The association of retinal arteriolar
disease with macrovascular disease may be caused by
microvascular changes in the heart and brain similar to those
found in the retina.
We did not find an association between retinal vascular
calibre and neuropathy. We have no knowledge of other
studies in type 1 diabetes in which microvascular risk
factors for neuropathy and nephropathy were directly
compared. Our findings indicate that there may be subtle
differences in the pathogenesis of neuropathy as compared
with nephropathy. This requires further investigation.
We observed a generalised narrowing of retinal arterioles
and venules in eyes that had been treated with panretinal
photocoagulation. This is consistent with clinical observation
of narrower retinal vessels after laser treatment [1], reflecting
reduced blood flow secondary to a lower metabolic demand
caused by the destruction of viable retinal tissue [9].
A major strength of the present study is the population-
based design that minimises the risk of referral bias. Some
limitations need to be addressed. First, these observations
were cross-sectional, which limits our ability to determine
antecedent-consequent relations. Thus, we cannot deter-
mine if retinal arteriolar narrowing predicts nephropathy
and macrovascular disease or vice versa. Second, the
observations reported may have been affected by survival
bias given the well-known association between retinal
arteriolar narrowing and mortality in diabetic patients [4].
Finally, we were not able to control for variations in
pulsatility associated with the cardiac cycle. A variation in
diameter of 6–17% for arterioles and 2–11% for venules
has been reported [10]. Our findings may be attenuated by
this variation.
In summary, in a population-based cohort of Danish type
1 diabetic patients, we demonstrate associations between
Table 2 Association of retinal vascular calibre and diabetes-related complications
Retinal vascular
calibre











1.68 (1.20–2.34)* 2.17 (1.29–3.68)* 1.27 (0.94–1.72) 1.10 (0.70–1.71) 1.95 (1.34–2.86)* 3.17 (1.59–6.34)*
Tertile 1, ≤132.4 µm 62 2.28 (1.04–5.00)* 2.28 (0.80–6.55) 1.41 (0.69–2.89) 0.93 (0.37–2.38) 3.99 (1.61–9.93)* 6.86 (1.75–26.9)*
Tertile 2, 132.5–
147.3 µm
62 1.28 (0.56–2.91) 1.34 (0.53–3.38) 0.62 (0.30–1.30) 0.51 (0.23–1.14) 0.69 (0.22–2.13) 0.51 (0.12–2.12)




0.90 (0.65–1.23) 1.43 (0.85–2.40) 0.80 (0.59–1.09) 0.84 (0.53–1.33) 0.86 (0.60–1.25) 1.78 (0.91–3.46)
Tertile 1, ≤199.5 µm 62 1.00 1.00 1.00 1.00 1.00 1.00
Tertile 2, 199.6–
218.9 µm
62 0.60 (0.28–1.29) 0.97 (0.40–2.37) 0.56 (0.27–1.15) 0.75 (0.33–1.67) 0.51 (0.20–1.27) 1.16 (0.36–3.76)
Tertile 3, ≥219.0 µm 62 0.65 (0.30–1.40) 1.17 (0.40–3.44) 0.78 (0.38–1.59) 1.16 (0.44–3.06) 0.83 (0.35–1.96) 2.69 (0.67–10.7)
AVR
Per SD decrease, 0.07 1.69 (1.17–2.44)* 1.48 (1.01–2.16)* 1.00 (0.74–1.36) 0.95 (0.69–1.31) 2.08 (1.32–3.28)* 1.79 (1.09–2.95)*
Tertile 1, ≤0.63 56 3.17 (1.44–6.95)* 2.34 (1.01–5.39)* 0.92 (0.44–1.91) 0.80 (0.37–1.73) 3.71 (1.40–9.82)* 2.54 (0.85–7.59)
Tertile 2, 0.64–0.69 60 1.04 (0.46–2.37) 0.88 (0.37–2.07) 1.05 (0.52–2.12) 0.94 (0.46–1.93) 2.45 (0.93–6.44) 2.24 (0.78–6.43)
Tertile 3, ≥0.70 70 1.00 1.00 1.00 1.00 1.00 1.00
Values are odds ratio (95% CI)
The multivariate models were adjusted for age, sex, duration of diabetes, HbA1c, systolic blood pressure and pack-years of smoking. Multivariate
models for subgroups stratified according to CRAE, CRVE or AVR were also adjusted for the stratifying variable. *Statistically significant, p<0.05
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retinal arteriolar narrowing, nephropathy and macrovascular
disease, independent of common risk factors. If supported
by prospective studies, retinal vascular measurements may
be useful as an additional tool to predict diabetic patients at
risk of debilitating complications.
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